R
Robert E. Gerszten
Researcher at Beth Israel Deaconess Medical Center
Publications - 337
Citations - 32894
Robert E. Gerszten is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 78, co-authored 257 publications receiving 26320 citations. Previous affiliations of Robert E. Gerszten include Beth Israel Deaconess Hospital & Broad Institute.
Papers
More filters
Journal ArticleDOI
Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Kathleen M McClain,Joshua N. Sampson,Jessica L. Petrick,Kaitlyn M Mazzilli,Robert E. Gerszten,Clary B. Clish,Mark P. Purdue,Loren Lipworth,Steven C. Moore +8 more
TL;DR: In this article , a 1:1 matched case-control study nested within the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was conducted to identify RCC-associated metabolites.
Journal ArticleDOI
Abstract 15719: Proteomic Analyses Reveal Mechanistic Links Between Clonal Hematopoiesis of Indeterminate Potential and Coronary Artery Disease
Zhi Yu,Bing Yu,Amelie Vromman,Sumeet A. Khetarpal,Michael C. Honigberg,Amy E. Lin,Daniel H. Katz,Usman A. Tahir,Joshua S. Weinstock,Siddhartha Jaiswal,Thomas R. Austin,Vasan S. Ramachandran,Gina M. Peloso,JoAnn E. Manson,Bernhard Haring,Charles Kooperberg,Alexander P. Reiner,Joshua A Bis,Bruce M. Psaty,Adolfo Correa,Leslie A. Lange,Wendy S. Post,Jerome I. Rotter,Stephen S. Rich,James F. Wilson,Christie M. Ballantyne,Josef Coresh,Vijay Austin Sankaran,Peter Libby,Alexander G. Bick,Benjamin L. Ebert,Robert E. Gerszten,Pradeep Natarajan +32 more
TL;DR: In this article , the authors studied the associations of CHIP with the plasma proteins and CAD risk in four Trans-Omics for Precision Medicine (TOPMed) longitudinal cohorts.
Journal ArticleDOI
Intramuscular administration of glyoxylate rescues swine from lethal cyanide poisoning and ameliorates the biochemical sequalae of cyanide intoxication
Vikhyat S. Bebarta,Xu Shi,Shunning Zheng,Tara B. Hendry-Hofer,Carter C Severance,Matthew M. Behymer,Gerry R. Boss,Sari B. Mahon,Matthew Brenner,Gregory T. Knipp,V. Jo Davisson,Randall T. Peterson,Calum A. MacRae,Jared Rutter,Robert E. Gerszten,Anjali K. Nath +15 more
TL;DR: In this article , the authors evaluated the efficacy of intramuscular glyoxylate on clinical, metabolic, and biochemical endpoints in a swine model of cyanide poisoning.
Patent
Lipidomic Biomarkers of Diabetes
TL;DR: In this article, a method for predicting a subject's risk of developing a glucose-related metabolic disorder, e.g., diabetes, was proposed, which relates to methods for selecting and monitoring a treatment for a glucose related metabolic disorder.
Journal ArticleDOI
Abstract 15241: Mixed Meal Tolerance Test Elicits Distinct Metabolite Kinetics for Individuals With and Without Diabetes
Michael Y. Mi,Mark Whitlock,Xu Shi,Laurie A. Farrell,Victoria M. Bhambhani,Juweria Quadir,Matthew Blatnik,Kyle P. Wald,Brendan Tierney,Peter Loudon,Zsu Zsu Chen,Rachel J. Roth Flach,Robert E. Gerszten +12 more
TL;DR: In this paper , a mixed meal tolerance test (MMTT) was administered to 13 adults with diabetes treated by metformin alone and 11 age and sex matched controls, and adjusted BCAA levels were higher in those with diabetes at 120 minutes.